BOD — Bod Science Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Bod Science, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6 | 7.44 | 5.09 | 3.32 | 2.86 |
| Cost of Revenue | |||||
| Gross Profit | 2.13 | 3.52 | 2.16 | 2.3 | 2.25 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.8 | 11.7 | 10.5 | 11.6 | 9.17 |
| Operating Profit | -4.78 | -4.26 | -5.41 | -8.26 | -6.31 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -4.82 | -4.23 | -5.41 | -7.95 | -6.41 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.82 | -4.23 | -5.41 | -7.95 | -6.41 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.82 | -4.23 | -5.41 | -7.95 | -6.41 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.82 | -4.23 | -5.41 | -7.95 | -6.41 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.05 | -0.043 | -0.052 | -0.055 | -0.017 |